Gray, Keyaria D.
,
Dudash, Kathryn
Escobar, Carla
Freel, Colman
Harrison, Tylah
McMillan, Chandler
Puia-Dumitrescu, Mihai
Cotten, C. Michael
Benjamin, Robert
Clark, Reese H.
Benjamin, Daniel K. Jr.
Greenberg, Rachel G. http://orcid.org/0000-0003-4156-8543
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (HHSN275201000003I)
Article History
Received: 5 April 2018
Revised: 16 July 2018
Accepted: 1 August 2018
First Online: 11 September 2018
Compliance with ethical standards
:
: Dr. DK Benjamin receives support from the National Institutes of Health (award 2K24HD058735-06, National Institute of Child Health and Human Development (HHSN275201000003I), National Institute of Allergy and Infectious Diseases (HHSN272201500006I), ECHO Program (1U2COD023375-01), and the National Center for Advancing Translational Sciences (1U24TR001608-01); he also receives research support from Cempra Pharmaceuticals (subaward to HHSO100201300009C) and consulting payments from AstraZeneca, Cempra, Shionogi Inc., The Medicines Company, Allergan, Astellas Pharma, Cidara Therapeutics, Purdue Pharma, and UCB Biosciences, Inc. Dr. R Benjamin serves on the Speaker’s Bureau for Pfizer. Dr. Clark is an employee of Pediatrix Medical Group, Inc. Dr. Cotten receives grant funding from the NIH (5U10 HD040492-16 and 1R01-EY025009-01A1). Dr. Greenberg receives salary support for research from NIH awards (HHSN 275201000003I, HHSN 272201300017I, HHSN200201253663), and from the Food and Drug Administration (HHSF223201610082C). The other authors declare that they have no conflict of interest.